Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice.

Xie YJ, Dougan M, Jailkhani N, Ingram J, Fang T, Kummer L, Momin N, Pishesha N, Rickelt S, Hynes RO, Ploegh H.

Proc Natl Acad Sci U S A. 2019 Apr 16;116(16):7624-7631. doi: 10.1073/pnas.1817147116. Epub 2019 Apr 1.

PMID:
30936321
2.

Improving hematopoietic recovery through modeling and modulation of the mesenchymal stromal cell secretome.

Liu FD, Tam K, Pishesha N, Poon Z, Van Vliet KJ.

Stem Cell Res Ther. 2018 Oct 24;9(1):268. doi: 10.1186/s13287-018-0982-2.

3.

Sortase A: A Model for Transpeptidation and Its Biological Applications.

Pishesha N, Ingram JR, Ploegh HL.

Annu Rev Cell Dev Biol. 2018 Oct 6;34:163-188. doi: 10.1146/annurev-cellbio-100617-062527. Epub 2018 Aug 15. Review.

PMID:
30110557
4.

Enhanced phosphocholine metabolism is essential for terminal erythropoiesis.

Huang NJ, Lin YC, Lin CY, Pishesha N, Lewis CA, Freinkman E, Farquharson C, Millán JL, Lodish H.

Blood. 2018 Jun 28;131(26):2955-2966. doi: 10.1182/blood-2018-03-838516. Epub 2018 Apr 30.

PMID:
29712634
5.

Targeting Cytokine Therapy to the Pancreatic Tumor Microenvironment Using PD-L1-Specific VHHs.

Dougan M, Ingram JR, Jeong HJ, Mosaheb MM, Bruck PT, Ali L, Pishesha N, Blomberg O, Tyler PM, Servos MM, Rashidian M, Nguyen QD, von Andrian UH, Ploegh HL, Dougan SK.

Cancer Immunol Res. 2018 Apr;6(4):389-401. doi: 10.1158/2326-6066.CIR-17-0495. Epub 2018 Feb 19.

6.

Localized CD47 blockade enhances immunotherapy for murine melanoma.

Ingram JR, Blomberg OS, Sockolosky JT, Ali L, Schmidt FI, Pishesha N, Espinosa C, Dougan SK, Garcia KC, Ploegh HL, Dougan M.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10184-10189. doi: 10.1073/pnas.1710776114. Epub 2017 Sep 5.

7.

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin.

Huang NJ, Pishesha N, Mukherjee J, Zhang S, Deshycka R, Sudaryo V, Dong M, Shoemaker CB, Lodish HF.

Nat Commun. 2017 Sep 4;8(1):423. doi: 10.1038/s41467-017-00448-0.

8.

Site-Specific Protein Labeling via Sortase-Mediated Transpeptidation.

Antos JM, Ingram J, Fang T, Pishesha N, Truttmann MC, Ploegh HL.

Curr Protoc Protein Sci. 2017 Aug 1;89:15.3.1-15.3.19. doi: 10.1002/cpps.38.

9.

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease.

Pishesha N, Bilate AM, Wibowo MC, Huang NJ, Li Z, Deshycka R, Bousbaine D, Li H, Patterson HC, Dougan SK, Maruyama T, Lodish HF, Ploegh HL.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3157-3162. doi: 10.1073/pnas.1701746114. Epub 2017 Mar 7. Erratum in: Proc Natl Acad Sci U S A. 2017 Apr 25;114(17 ):E3583. Dhesycka, Rhogerry [corrected to Deshycka, Rhogerry].

10.

Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells.

Li H, Shi J, Huang NJ, Pishesha N, Natarajan A, Eng JC, Lodish HF.

Haematologica. 2016 Jun;101(6):e216-9. doi: 10.3324/haematol.2015.135723. Epub 2016 Mar 11. No abstract available.

11.

Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes.

Shi J, Kundrat L, Pishesha N, Bilate A, Theile C, Maruyama T, Dougan SK, Ploegh HL, Lodish HF.

Proc Natl Acad Sci U S A. 2014 Jul 15;111(28):10131-6. doi: 10.1073/pnas.1409861111. Epub 2014 Jun 30.

12.

Transcriptional divergence and conservation of human and mouse erythropoiesis.

Pishesha N, Thiru P, Shi J, Eng JC, Sankaran VG, Lodish HF.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4103-8. doi: 10.1073/pnas.1401598111. Epub 2014 Mar 3.

13.

Age dependent increase in the levels of osteopontin inhibits skeletal muscle regeneration.

Paliwal P, Pishesha N, Wijaya D, Conboy IM.

Aging (Albany NY). 2012 Aug;4(8):553-66.

Supplemental Content

Loading ...
Support Center